| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 1.75e-06 | 4 | 153 | 3 | GO:0004082 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 1.75e-06 | 4 | 153 | 3 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 1.75e-06 | 4 | 153 | 3 | GO:0004619 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 7.30e-06 | 17 | 153 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | intramolecular phosphotransferase activity | 6.96e-05 | 11 | 153 | 3 | GO:0016868 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.01e-04 | 32 | 153 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.01e-04 | 32 | 153 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.19e-04 | 13 | 153 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.19e-04 | 13 | 153 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 5.75e-04 | 5 | 153 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | antiporter activity | 6.87e-04 | 138 | 153 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 8.57e-04 | 6 | 153 | 2 | GO:0008510 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 3.28e-08 | 44 | 153 | 7 | GO:0002717 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 2.05e-07 | 35 | 153 | 6 | GO:0032816 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 4.71e-07 | 40 | 153 | 6 | GO:0045954 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6.35e-07 | 23 | 153 | 5 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 9.91e-07 | 25 | 153 | 5 | GO:0002483 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | THEMIS2 PIK3AP1 RASGRP4 ZC3H12A USP9X HLA-E RAET1G DGKZ IRF3 ECSIT STAT5A STAT5B CFD LAT TAX1BP1 MARK4 ERMAP ULBP2 RAET1L FYB2 SEC14L1 | 1.20e-06 | 845 | 153 | 21 | GO:0050778 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.17e-06 | 80 | 153 | 7 | GO:0002715 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 3.60e-06 | 32 | 153 | 5 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 4.94e-06 | 16 | 153 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | regulation of immune response | THEMIS2 PIK3AP1 RASGRP4 ZC3H12A ERAP1 USP9X HLA-E RAET1G DGKZ IRF3 ECSIT STAT2 STAT5A STAT5B CFD LAT TAX1BP1 MARK4 ERMAP ULBP2 RAET1L FYB2 SEC14L1 | 5.22e-06 | 1085 | 153 | 23 | GO:0050776 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 5.99e-06 | 61 | 153 | 6 | GO:0032814 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 6.43e-06 | 17 | 153 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 6.43e-06 | 17 | 153 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | PIK3AP1 RASGRP4 ERAP1 HLA-E RAET1G IRF3 ECSIT STAT2 STAT5A STAT5B TAX1BP1 MARK4 ULBP2 RAET1L SEC14L1 | 7.70e-06 | 519 | 153 | 15 | GO:0045088 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 8.21e-06 | 18 | 153 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 1.27e-05 | 41 | 153 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | PIK3AP1 RASGRP4 HLA-E RAET1G IRF3 ECSIT STAT5A STAT5B TAX1BP1 MARK4 ULBP2 RAET1L SEC14L1 | 1.56e-05 | 420 | 153 | 13 | GO:0045089 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.70e-05 | 109 | 153 | 7 | GO:0002228 | |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 1.92e-05 | 22 | 153 | 4 | GO:0071360 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.15e-05 | 76 | 153 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | PIK3AP1 RASGRP4 ZC3H12A ERAP1 HLA-E RAET1G IRF3 ECSIT STAT2 STAT5A STAT5B TAX1BP1 MARK4 ULBP2 RAET1L SEC14L1 | 2.42e-05 | 643 | 153 | 16 | GO:0002831 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 2.69e-05 | 79 | 153 | 6 | GO:0001912 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 3.25e-05 | 9 | 153 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 3.26e-05 | 25 | 153 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | PIK3AP1 RASGRP4 HLA-E RAET1G IRF3 ECSIT STAT5A STAT5B TAX1BP1 MARK4 ULBP2 RAET1L SEC14L1 | 3.28e-05 | 451 | 153 | 13 | GO:0002833 |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | THEMIS2 PIK3AP1 RASGRP4 ZC3H12A USP9X HLA-E RAET1G DGKZ IRF3 DCSTAMP ECSIT GSK3B STAT5A STAT5B CFD LAT TAX1BP1 MARK4 ERMAP ULBP2 RAET1L FYB2 SEC14L1 | 4.48e-05 | 1242 | 153 | 23 | GO:0002684 |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 4.96e-05 | 88 | 153 | 6 | GO:0031343 | |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 5.19e-05 | 28 | 153 | 4 | GO:0071359 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | THEMIS2 PIK3AP1 ZC3H12A USP9X DGKZ IRF3 ECSIT LAT TAX1BP1 ERMAP FYB2 | 7.86e-05 | 359 | 153 | 11 | GO:0002429 |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 8.56e-05 | 97 | 153 | 6 | GO:0045428 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 1.01e-04 | 100 | 153 | 6 | GO:0080164 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 1.21e-04 | 65 | 153 | 5 | GO:0045429 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 1.31e-04 | 150 | 153 | 7 | GO:0002708 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.33e-04 | 105 | 153 | 6 | GO:0042267 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 1.40e-04 | 67 | 153 | 5 | GO:1904407 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 1.63e-04 | 3 | 153 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | THEMIS2 PIK3AP1 ZC3H12A USP9X DGKZ IRF3 ECSIT LAT TAX1BP1 ERMAP FYB2 | 1.74e-04 | 393 | 153 | 11 | GO:0002768 |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.77e-04 | 38 | 153 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 1.89e-04 | 112 | 153 | 6 | GO:0006809 | |
| GeneOntologyBiologicalProcess | T cell receptor signaling pathway | 1.95e-04 | 160 | 153 | 7 | GO:0050852 | |
| GeneOntologyBiologicalProcess | activation of immune response | THEMIS2 PIK3AP1 ZC3H12A USP9X DGKZ IRF3 ECSIT CFD LAT TAX1BP1 MARK4 ERMAP FYB2 SEC14L1 | 2.30e-04 | 623 | 153 | 14 | GO:0002253 |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | THEMIS2 PIK3AP1 ZC3H12A USP9X DGKZ IRF3 ECSIT LAT TAX1BP1 MARK4 ERMAP FYB2 SEC14L1 | 2.52e-04 | 553 | 153 | 13 | GO:0002757 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 2.54e-04 | 76 | 153 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.62e-04 | 42 | 153 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 2.88e-04 | 121 | 153 | 6 | GO:0046209 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 3.14e-04 | 123 | 153 | 6 | GO:2001057 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.28e-04 | 124 | 153 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 3.28e-04 | 124 | 153 | 6 | GO:0030101 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 3.36e-04 | 175 | 153 | 7 | GO:0002705 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | PIK3AP1 RASGRP4 HLA-E RAET1G IRF3 ECSIT STAT5A STAT5B TAX1BP1 MARK4 ULBP2 RAET1L SEC14L1 | 4.59e-04 | 589 | 153 | 13 | GO:0031349 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | NPPB ZC3H12A FN1 SH2B3 ERAP1 ACHE L1CAM CUL7 DCC SIX1 GSK3B STAT2 STRIP2 GTF2I DLC1 FGD5 SEMA6A CDH1 FGD6 | 4.65e-04 | 1090 | 153 | 19 | GO:0022603 |
| GeneOntologyBiologicalProcess | synapse assembly | 5.01e-04 | 308 | 153 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | synapse organization | SDK2 ACHE USP9X L1CAM CKAP5 DGKZ SIX1 GSK3B HMCN2 CASKIN1 IGSF9 IGSF9B MDGA1 CDH1 | 5.94e-04 | 685 | 153 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 6.43e-04 | 53 | 153 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 6.79e-04 | 94 | 153 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | THEMIS2 PIK3AP1 ZC3H12A USP9X DGKZ IRF3 ECSIT LAT TAX1BP1 MARK4 ERMAP FYB2 SEC14L1 | 6.86e-04 | 615 | 153 | 13 | GO:0002764 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 7.40e-04 | 55 | 153 | 4 | GO:0043330 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 8.09e-04 | 147 | 153 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 9.40e-04 | 101 | 153 | 5 | GO:0030641 | |
| Domain | Ig_I-set | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 3.22e-12 | 190 | 151 | 16 | IPR013098 |
| Domain | I-set | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 3.22e-12 | 190 | 151 | 16 | PF07679 |
| Domain | IGc2 | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 8.05e-11 | 235 | 151 | 16 | SM00408 |
| Domain | Ig_sub2 | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 8.05e-11 | 235 | 151 | 16 | IPR003598 |
| Domain | FN3 | SDK2 MYLK FN1 L1CAM OBSCN DCC IGDCC4 IGSF9 COL14A1 MYOM2 IGSF9B MDGA1 MYBPC2 | 3.52e-09 | 185 | 151 | 13 | SM00060 |
| Domain | fn3 | SDK2 MYLK FN1 L1CAM OBSCN DCC IGDCC4 IGSF9 COL14A1 MYOM2 IGSF9B MYBPC2 | 7.97e-09 | 162 | 151 | 12 | PF00041 |
| Domain | FN3 | SDK2 MYLK FN1 L1CAM OBSCN DCC IGDCC4 IGSF9 COL14A1 MYOM2 IGSF9B MDGA1 MYBPC2 | 8.52e-09 | 199 | 151 | 13 | PS50853 |
| Domain | FN3_dom | SDK2 MYLK FN1 L1CAM OBSCN DCC IGDCC4 IGSF9 COL14A1 MYOM2 IGSF9B MDGA1 MYBPC2 | 1.53e-08 | 209 | 151 | 13 | IPR003961 |
| Domain | IG | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 ERMAP IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 5.58e-08 | 421 | 151 | 17 | SM00409 |
| Domain | Ig_sub | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 ERMAP IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 5.58e-08 | 421 | 151 | 17 | IPR003599 |
| Domain | IG_LIKE | SDK2 MXRA5 MYLK L1CAM HLA-E OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 ERMAP IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 9.51e-08 | 491 | 151 | 18 | PS50835 |
| Domain | Ig-like_dom | SDK2 MXRA5 MYLK L1CAM HLA-E OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 ERMAP IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 1.36e-07 | 503 | 151 | 18 | IPR007110 |
| Domain | Ig-like_fold | SDK2 MXRA5 MYLK FN1 L1CAM HLA-E OBSCN DCC SLC4A2 IGDCC4 PXDN HMCN2 LRIG1 ERMAP IGSF9 COL14A1 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 2.57e-07 | 706 | 151 | 21 | IPR013783 |
| Domain | - | 5.01e-07 | 9 | 151 | 4 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 5.01e-07 | 9 | 151 | 4 | IPR013769 | |
| Domain | Band_3_cyto | 5.01e-07 | 9 | 151 | 4 | PF07565 | |
| Domain | PTrfase/Anion_transptr | 8.30e-07 | 10 | 151 | 4 | IPR016152 | |
| Domain | HCO3_transpt_euk | 8.30e-07 | 10 | 151 | 4 | IPR003020 | |
| Domain | HCO3_cotransp | 8.30e-07 | 10 | 151 | 4 | PF00955 | |
| Domain | HCO3_transpt_C | 8.30e-07 | 10 | 151 | 4 | IPR011531 | |
| Domain | - | SDK2 MXRA5 MYLK FN1 L1CAM HLA-E OBSCN DCC IGDCC4 PXDN LRIG1 ERMAP IGSF9 COL14A1 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 1.75e-06 | 663 | 151 | 19 | 2.60.40.10 |
| Domain | Phosphogly_mut1 | 2.06e-06 | 4 | 151 | 3 | IPR005952 | |
| Domain | STAT_TF_DNA-bd_sub | 1.77e-05 | 7 | 151 | 3 | IPR012345 | |
| Domain | STAT | 1.77e-05 | 7 | 151 | 3 | IPR001217 | |
| Domain | STAT_int | 1.77e-05 | 7 | 151 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.77e-05 | 7 | 151 | 3 | IPR013801 | |
| Domain | STAT_bind | 1.77e-05 | 7 | 151 | 3 | PF02864 | |
| Domain | STAT_int | 1.77e-05 | 7 | 151 | 3 | PF02865 | |
| Domain | - | 1.77e-05 | 7 | 151 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.77e-05 | 7 | 151 | 3 | PF01017 | |
| Domain | - | 1.77e-05 | 7 | 151 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.77e-05 | 7 | 151 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.77e-05 | 7 | 151 | 3 | IPR015988 | |
| Domain | - | 1.77e-05 | 7 | 151 | 3 | 2.60.40.630 | |
| Domain | ANION_EXCHANGER_2 | 1.77e-05 | 7 | 151 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.77e-05 | 7 | 151 | 3 | PS00219 | |
| Domain | MHC_I | 2.21e-05 | 21 | 151 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 2.21e-05 | 21 | 151 | 4 | IPR001039 | |
| Domain | STAT_TF_alpha | 2.82e-05 | 8 | 151 | 3 | IPR013800 | |
| Domain | - | 3.85e-05 | 24 | 151 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.85e-05 | 24 | 151 | 4 | IPR011161 | |
| Domain | PG/BPGM_mutase_AS | 4.20e-05 | 9 | 151 | 3 | IPR001345 | |
| Domain | PGAM | 5.96e-05 | 10 | 151 | 3 | SM00855 | |
| Domain | PG_MUTASE | 5.96e-05 | 10 | 151 | 3 | PS00175 | |
| Domain | His_Pase_superF_clade-1 | 1.08e-04 | 12 | 151 | 3 | IPR013078 | |
| Domain | His_Phos_1 | 1.08e-04 | 12 | 151 | 3 | PF00300 | |
| Domain | Cul7 | 1.94e-04 | 3 | 151 | 2 | PF11515 | |
| Domain | Anion_exchange_CS | 1.94e-04 | 3 | 151 | 2 | IPR018241 | |
| Domain | CPH_domain | 1.94e-04 | 3 | 151 | 2 | IPR021097 | |
| Domain | MHC_I/II-like_Ag-recog | 2.45e-04 | 38 | 151 | 4 | IPR011162 | |
| Domain | Rib_L2_dom2 | 3.87e-04 | 18 | 151 | 3 | IPR014722 | |
| Domain | - | 3.87e-04 | 18 | 151 | 3 | 2.30.30.30 | |
| Domain | - | 5.34e-04 | 20 | 151 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 5.34e-04 | 20 | 151 | 3 | IPR029033 | |
| Domain | Na/HCO3_transpt | 6.39e-04 | 5 | 151 | 2 | IPR003024 | |
| Domain | Anion_exchange | 6.39e-04 | 5 | 151 | 2 | IPR001717 | |
| Domain | K/Na/Ca-exchanger | 6.39e-04 | 5 | 151 | 2 | IPR004481 | |
| Domain | RNase_Zc3h12a | 1.33e-03 | 7 | 151 | 2 | PF11977 | |
| Domain | APC_su10/DOC_dom | 1.33e-03 | 7 | 151 | 2 | IPR004939 | |
| Domain | DOC | 1.33e-03 | 7 | 151 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.33e-03 | 7 | 151 | 2 | PF03256 | |
| Domain | RNase_Zc3h12_NYN | 1.33e-03 | 7 | 151 | 2 | IPR021869 | |
| Domain | APC10 | 1.33e-03 | 7 | 151 | 2 | SM01337 | |
| Domain | SH2 | 1.37e-03 | 101 | 151 | 5 | PF00017 | |
| Domain | IG_MHC | 1.41e-03 | 60 | 151 | 4 | PS00290 | |
| Domain | Cullin_neddylation_domain | 1.76e-03 | 8 | 151 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 1.76e-03 | 8 | 151 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.76e-03 | 8 | 151 | 2 | SM00884 | |
| Domain | ARM-type_fold | 1.78e-03 | 339 | 151 | 9 | IPR016024 | |
| Domain | SH2 | 2.00e-03 | 110 | 151 | 5 | SM00252 | |
| Domain | SH2 | 2.08e-03 | 111 | 151 | 5 | PS50001 | |
| Domain | SH2 | 2.17e-03 | 112 | 151 | 5 | IPR000980 | |
| Domain | - | 2.17e-03 | 112 | 151 | 5 | 3.30.505.10 | |
| Domain | Cullin_homology | 2.25e-03 | 9 | 151 | 2 | IPR016158 | |
| Domain | NaCa_Exmemb | 2.25e-03 | 9 | 151 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 2.25e-03 | 9 | 151 | 2 | PF01699 | |
| Domain | Cullin | 2.80e-03 | 10 | 151 | 2 | PF00888 | |
| Domain | Rap_GAP | 2.80e-03 | 10 | 151 | 2 | PF02145 | |
| Domain | CULLIN_2 | 2.80e-03 | 10 | 151 | 2 | PS50069 | |
| Domain | Cullin_N | 2.80e-03 | 10 | 151 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 2.80e-03 | 10 | 151 | 2 | PS01256 | |
| Domain | Rap_GAP_dom | 3.40e-03 | 11 | 151 | 2 | IPR000331 | |
| Domain | RAPGAP | 3.40e-03 | 11 | 151 | 2 | PS50085 | |
| Domain | Carboxylesterase_B_CS | 4.78e-03 | 13 | 151 | 2 | IPR019819 | |
| Domain | - | 4.78e-03 | 13 | 151 | 2 | 2.10.10.10 | |
| Domain | FN_type2_col-bd | 5.54e-03 | 14 | 151 | 2 | IPR000562 | |
| Domain | FN2_2 | 5.54e-03 | 14 | 151 | 2 | PS51092 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.54e-03 | 14 | 151 | 2 | PS00941 | |
| Domain | COesterase | 5.54e-03 | 14 | 151 | 2 | PF00135 | |
| Domain | FN2_1 | 5.54e-03 | 14 | 151 | 2 | PS00023 | |
| Domain | fn2 | 5.54e-03 | 14 | 151 | 2 | PF00040 | |
| Domain | FN2 | 5.54e-03 | 14 | 151 | 2 | SM00059 | |
| Domain | CarbesteraseB | 5.54e-03 | 14 | 151 | 2 | IPR002018 | |
| Domain | Cys-rich_flank_reg_C | 6.13e-03 | 90 | 151 | 4 | IPR000483 | |
| Domain | LRRCT | 6.13e-03 | 90 | 151 | 4 | SM00082 | |
| Domain | ARM-like | 6.46e-03 | 270 | 151 | 7 | IPR011989 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 6.60e-07 | 10 | 108 | 4 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 6.60e-07 | 10 | 108 | 4 | MM15073 | |
| Pubmed | Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. | 8.85e-08 | 3 | 156 | 3 | 32634742 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 33914812 | ||
| Pubmed | Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. | 8.85e-08 | 3 | 156 | 3 | 11250083 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 25212604 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 22228679 | ||
| Pubmed | Developmental activation of phosphoglycerate mutase-2 in the testis of the mouse. | 8.85e-08 | 3 | 156 | 3 | 2824255 | |
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 3.53e-07 | 4 | 156 | 3 | 20166740 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 25195573 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 8882725 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12421908 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12756263 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 19081632 | ||
| Pubmed | 7.53e-07 | 162 | 156 | 8 | 25826454 | ||
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 8.79e-07 | 5 | 156 | 3 | 24572784 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 8982867 | ||
| Pubmed | RPS6KA4 SH2B3 HLA-E CUL9 PGAM1 PXDN TAX1BP1 PGAM4 BUD31 CDH1 SEC23B | 1.03e-06 | 371 | 156 | 11 | 15747579 | |
| Pubmed | 1.43e-06 | 19 | 156 | 4 | 32075740 | ||
| Pubmed | Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. | 1.75e-06 | 6 | 156 | 3 | 11825567 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 10894171 | ||
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 27870635 | ||
| Pubmed | Ligands for murine NKG2D display heterogeneous binding behavior. | 1.75e-06 | 6 | 156 | 3 | 11857333 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 20219610 | ||
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 20976056 | ||
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 10675904 | ||
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 1.75e-06 | 6 | 156 | 3 | 19688209 | |
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 3.06e-06 | 7 | 156 | 3 | 16831899 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 25583577 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 3.06e-06 | 7 | 156 | 3 | 12039028 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 20870941 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 3.06e-06 | 7 | 156 | 3 | 30787931 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 12370332 | ||
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 3.06e-06 | 7 | 156 | 3 | 12634107 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 3.06e-06 | 7 | 156 | 3 | 24058793 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 11706048 | ||
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 3.06e-06 | 7 | 156 | 3 | 10526573 | |
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 26110920 | ||
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 24567357 | ||
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 4.88e-06 | 8 | 156 | 3 | 12645935 | |
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 16331648 | ||
| Pubmed | Chromosomal location of the murine anion exchanger genes encoding AE2 and AE3. | 4.88e-06 | 8 | 156 | 3 | 7894173 | |
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 7750641 | ||
| Pubmed | ABO, Rh, MNS, Duffy, Kidd,Yt, Scianna, and Colton blood group systems in indigenous Chinese. | 4.88e-06 | 8 | 156 | 3 | 15783300 | |
| Pubmed | 6.31e-06 | 27 | 156 | 4 | 32428860 | ||
| Pubmed | ENPP6 RALGAPA1 MAP9 MYBBP1A FN1 SRSF7 USP9X SIPA1L3 L1CAM CKAP5 DGKZ IDH2 PGAM1 GSK3B NDUFA12 LRIG1 SLC24A2 KIAA1217 CASKIN1 PGAM4 | 6.90e-06 | 1431 | 156 | 20 | 37142655 | |
| Pubmed | Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. | 7.29e-06 | 9 | 156 | 3 | 14764662 | |
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 31843895 | ||
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 7.29e-06 | 9 | 156 | 3 | 23136011 | |
| Pubmed | 9.09e-06 | 162 | 156 | 7 | 15174051 | ||
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 10200816 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 1.04e-05 | 10 | 156 | 3 | 38658806 | |
| Pubmed | A brain-specific homeobox gene, Bsx, is essential for proper postnatal growth and nursing. | 1.04e-05 | 10 | 156 | 3 | 17485440 | |
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 24069548 | ||
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 1.04e-05 | 10 | 156 | 3 | 11827464 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE NDOR1 SH2B3 SZT2 SIPA1L3 L1CAM HECTD4 OBSCN CUL9 MICALL1 ORC1 PRR12 PCNX4 CASKIN1 MARK4 LTBP3 STK40 | 1.05e-05 | 1105 | 156 | 17 | 35748872 |
| Pubmed | Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. | 1.42e-05 | 11 | 156 | 3 | 26656785 | |
| Pubmed | Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. | 1.42e-05 | 11 | 156 | 3 | 31570706 | |
| Pubmed | 1.53e-05 | 117 | 156 | 6 | 17145500 | ||
| Pubmed | Divergent Role for STAT5 in the Adaptive Responses of Natural Killer Cells. | 1.89e-05 | 12 | 156 | 3 | 33326784 | |
| Pubmed | 1.93e-05 | 182 | 156 | 7 | 15102471 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23151802 | ||
| Pubmed | Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase. | 2.00e-05 | 2 | 156 | 2 | 2822696 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 26999798 | ||
| Pubmed | T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy? | 2.00e-05 | 2 | 156 | 2 | 12434297 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 2.00e-05 | 2 | 156 | 2 | 31443474 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 2.00e-05 | 2 | 156 | 2 | 21127177 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 16289657 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25552366 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 2.00e-05 | 2 | 156 | 2 | 21431790 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 28500076 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21826656 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 2.00e-05 | 2 | 156 | 2 | 27264955 | |
| Pubmed | Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue. | 2.00e-05 | 2 | 156 | 2 | 35521515 | |
| Pubmed | Extracellular mRNA transported to the nucleus exerts translation-independent function. | 2.00e-05 | 2 | 156 | 2 | 34135341 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12414996 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22159083 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 20008792 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 33199496 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 16502315 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12217382 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 2.00e-05 | 2 | 156 | 2 | 12895410 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 31599926 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 10594041 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21036145 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 10486277 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 2.00e-05 | 2 | 156 | 2 | 16840779 | |
| Pubmed | Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease. | 2.00e-05 | 2 | 156 | 2 | 17214852 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 2.00e-05 | 2 | 156 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 2.00e-05 | 2 | 156 | 2 | 30377054 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 2.00e-05 | 2 | 156 | 2 | 32790723 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18492722 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 10066807 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 10835485 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35464049 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18286195 | ||
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | SDK2 MXRA5 MYLK L1CAM OBSCN DCC IGDCC4 PXDN HMCN2 LRIG1 IGSF9 LRRN2 MYOM2 IGSF9B MDGA1 MYBPC2 | 7.19e-16 | 161 | 102 | 16 | 593 |
| GeneFamily | Fibronectin type III domain containing | SDK2 MYLK FN1 L1CAM OBSCN DCC IGDCC4 IGSF9 COL14A1 MYOM2 IGSF9B MYBPC2 | 1.04e-10 | 160 | 102 | 12 | 555 |
| GeneFamily | Bisphosphoglycerate phosphatases | 6.94e-07 | 4 | 102 | 3 | 1082 | |
| GeneFamily | Immunoglobulin like domain containing | 1.45e-06 | 193 | 102 | 9 | 594 | |
| GeneFamily | SH2 domain containing | 2.67e-04 | 101 | 102 | 5 | 741 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 8.63e-04 | 8 | 102 | 2 | 658 | |
| GeneFamily | Cullins | 8.63e-04 | 8 | 102 | 2 | 1032 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 1.18e-03 | 37 | 102 | 3 | 454 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-09 | 197 | 156 | 10 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.07e-09 | 197 | 156 | 10 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.07e-09 | 197 | 156 | 10 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.68e-08 | 199 | 156 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-08 | 200 | 156 | 9 | 0655328373d1b58828e141ddb0dcbb2cce10dc50 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-07 | 176 | 156 | 8 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-07 | 176 | 156 | 8 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-07 | 191 | 156 | 8 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-07 | 191 | 156 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 193 | 156 | 8 | 536b277d90070c4571c592a3c6323b4bf4819f67 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 193 | 156 | 8 | 0499611c21d283321ef6dd24add154dea48da1b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-07 | 194 | 156 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-07 | 195 | 156 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-07 | 195 | 156 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.70e-07 | 196 | 156 | 8 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.07e-07 | 198 | 156 | 8 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.27e-07 | 199 | 156 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.27e-07 | 199 | 156 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.47e-07 | 200 | 156 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.47e-07 | 200 | 156 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.47e-07 | 200 | 156 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.47e-07 | 200 | 156 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 164 | 156 | 7 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.45e-06 | 171 | 156 | 7 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 2.45e-06 | 171 | 156 | 7 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-06 | 172 | 156 | 7 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | Healthy/Control-MAIT|Healthy/Control / Disease group and Cell class | 2.65e-06 | 173 | 156 | 7 | 56247c1e07477a8922fe2e3950ae05e2217fd77c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.08e-06 | 177 | 156 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.08e-06 | 177 | 156 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 178 | 156 | 7 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-06 | 180 | 156 | 7 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-06 | 180 | 156 | 7 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-06 | 183 | 156 | 7 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 187 | 156 | 7 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 187 | 156 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.42e-06 | 187 | 156 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 187 | 156 | 7 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 190 | 156 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 190 | 156 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-06 | 191 | 156 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-06 | 191 | 156 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-06 | 191 | 156 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.08e-06 | 191 | 156 | 7 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-06 | 192 | 156 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-06 | 192 | 156 | 7 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-06 | 192 | 156 | 7 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-06 | 192 | 156 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-06 | 192 | 156 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 156 | 7 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 193 | 156 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.63e-06 | 194 | 156 | 7 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-06 | 194 | 156 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-06 | 194 | 156 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.63e-06 | 194 | 156 | 7 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.63e-06 | 194 | 156 | 7 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.82e-06 | 195 | 156 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.82e-06 | 195 | 156 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-06 | 196 | 156 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-06 | 196 | 156 | 7 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-06 | 196 | 156 | 7 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-06 | 196 | 156 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.02e-06 | 196 | 156 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-06 | 197 | 156 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-06 | 198 | 156 | 7 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-06 | 198 | 156 | 7 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-06 | 198 | 156 | 7 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-06 | 198 | 156 | 7 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.43e-06 | 198 | 156 | 7 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-06 | 199 | 156 | 7 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 199 | 156 | 7 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.65e-06 | 199 | 156 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.65e-06 | 199 | 156 | 7 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 6.65e-06 | 199 | 156 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.65e-06 | 199 | 156 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 199 | 156 | 7 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 199 | 156 | 7 | 50abd20eb461927fde0ec5caae501d7f2277cf78 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| Drug | AC1L2XXT | 1.21e-06 | 4 | 154 | 3 | CID000105047 | |
| Disease | anemia (implicated_via_orthology) | 9.07e-07 | 15 | 153 | 4 | DOID:2355 (implicated_via_orthology) | |
| Disease | Coronary Arteriosclerosis | 2.26e-05 | 65 | 153 | 5 | C0010054 | |
| Disease | Coronary Artery Disease | 2.26e-05 | 65 | 153 | 5 | C1956346 | |
| Disease | level of UL16-binding protein 6 in blood serum | 2.67e-05 | 2 | 153 | 2 | OBA_2043185 | |
| Disease | severe acute respiratory syndrome, COVID-19 | MXRA5 USP9X TG MICALL1 PXDN FAM222B KIAA1217 ULBP2 RAET1L LTBP3 | 1.20e-04 | 447 | 153 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | factor VIII measurement, Ischemic stroke | 1.25e-04 | 19 | 153 | 3 | EFO_0004630, HP_0002140 | |
| Disease | semaphorin-6A measurement | 1.59e-04 | 4 | 153 | 2 | EFO_0020721 | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 2.64e-04 | 5 | 153 | 2 | EFO_0801690 | |
| Disease | pulse pressure measurement | NPPB MXRA5 ABO FN1 CKAP5 GDF10 SNX19 ERLEC1 STAT5B ARL6IP6 DLC1 LRIG1 MRC2 KIAA1217 FGD5 LTBP3 BRD1 FGD6 | 3.34e-04 | 1392 | 153 | 18 | EFO_0005763 |
| Disease | Carcinoma, Lobular | 3.95e-04 | 6 | 153 | 2 | C0206692 | |
| Disease | venous thromboembolism, fibrinogen measurement | 4.13e-04 | 67 | 153 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 5.01e-04 | 30 | 153 | 3 | EFO_0004629, HP_0002140 | |
| Disease | myocardial infarction | 5.04e-04 | 350 | 153 | 8 | EFO_0000612 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 5.51e-04 | 7 | 153 | 2 | DOID:3457 (is_marker_for) | |
| Disease | Growth Disorders | 8.61e-04 | 36 | 153 | 3 | C0018273 | |
| Disease | Animal Mammary Neoplasms | 8.89e-04 | 142 | 153 | 5 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 8.89e-04 | 142 | 153 | 5 | C1257925 | |
| Disease | t-cell surface glycoprotein CD5 measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0803134 | |
| Disease | epilepsy (is_implicated_in) | 9.39e-04 | 9 | 153 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | hemorrhoid | 1.04e-03 | 147 | 153 | 5 | EFO_0009552 | |
| Disease | parental longevity | 1.14e-03 | 494 | 153 | 9 | EFO_0007796 | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0008200 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0008321 | |
| Disease | mean arterial pressure | 1.23e-03 | 499 | 153 | 9 | EFO_0006340 | |
| Disease | diabetes mellitus (is_marker_for) | 1.26e-03 | 41 | 153 | 3 | DOID:9351 (is_marker_for) | |
| Disease | Mammary Neoplasms, Experimental | 1.31e-03 | 155 | 153 | 5 | C0024668 | |
| Disease | Ductal Carcinoma | 1.42e-03 | 11 | 153 | 2 | C1176475 | |
| Disease | Aortic Valve Insufficiency | 1.42e-03 | 11 | 153 | 2 | C0003504 | |
| Disease | forced expiratory volume, body mass index | 1.42e-03 | 11 | 153 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | Malignant neoplasm of breast | THEMIS2 FN1 PNLIPRP1 VPS72 ACHE OBSCN H6PD GDF10 STAT5A MICALL1 TAX1BP1 MROH7 FGD5 CDH1 | 1.45e-03 | 1074 | 153 | 14 | C0006142 |
| Disease | left ventricular systolic function measurement | 1.55e-03 | 44 | 153 | 3 | EFO_0008206 | |
| Disease | Adenocarcinoma of large intestine | 1.59e-03 | 96 | 153 | 4 | C1319315 | |
| Disease | Carcinomatosis | 1.64e-03 | 163 | 153 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.64e-03 | 163 | 153 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.64e-03 | 163 | 153 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.64e-03 | 163 | 153 | 5 | C0205696 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.65e-03 | 45 | 153 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Carcinoma | 1.68e-03 | 164 | 153 | 5 | C0007097 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.70e-03 | 12 | 153 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.70e-03 | 12 | 153 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.70e-03 | 12 | 153 | 2 | C1864877 | |
| Disease | Hematologic Neoplasms | 1.70e-03 | 12 | 153 | 2 | C0376545 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.70e-03 | 12 | 153 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.70e-03 | 12 | 153 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.70e-03 | 12 | 153 | 2 | C1848172 | |
| Disease | frontal fibrosing alopecia | 1.99e-03 | 48 | 153 | 3 | EFO_0009855 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.01e-03 | 13 | 153 | 2 | C4041558 | |
| Disease | Leukemia, Myelocytic, Acute | 2.13e-03 | 173 | 153 | 5 | C0023467 | |
| Disease | tonsillectomy risk measurement | 2.43e-03 | 260 | 153 | 6 | EFO_0007924 | |
| Disease | heel bone mineral density, urate measurement | 2.65e-03 | 182 | 153 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0004791, HP_0002140 | |
| Disease | heart failure | 2.84e-03 | 185 | 153 | 5 | EFO_0003144 | |
| Disease | large artery stroke | 2.89e-03 | 113 | 153 | 4 | EFO_0005524 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 3.06e-03 | 16 | 153 | 2 | EFO_0004792, HP_0002140 | |
| Disease | Pre-Eclampsia | 3.06e-03 | 16 | 153 | 2 | C0032914 | |
| Disease | polyp of colon | 3.10e-03 | 56 | 153 | 3 | MONDO_0021400 | |
| Disease | heart disease (biomarker_via_orthology) | 3.45e-03 | 17 | 153 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | immature granulocyte count | 3.45e-03 | 17 | 153 | 2 | EFO_0803542 | |
| Disease | Night blindness, congenital stationary | 3.45e-03 | 17 | 153 | 2 | C0339535 | |
| Disease | factor XI measurement, Ischemic stroke | 3.45e-03 | 17 | 153 | 2 | EFO_0004694, HP_0002140 | |
| Disease | eosinophil count | THEMIS2 RASGRP4 ABO SH2B3 CYP8B1 SIPA1L3 HECTD4 SEC31A H6PD STAT5B TG PXDN MARK4 ZC3H12D LTBP3 SPIDR | 4.63e-03 | 1488 | 153 | 16 | EFO_0004842 |
| Disease | histidine measurement | 4.93e-03 | 66 | 153 | 3 | EFO_0009769 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REIKAPIRAAWSPPS | 36 | Q9H8V8 | |
| RRFLPPEPKQPWSGV | 76 | P22303 | |
| GLTLSPKPWIPVLER | 126 | Q6NS38 | |
| IPFRVNWPGTEFSLP | 41 | Q96DZ1 | |
| RGWVINPLGEKSPFP | 976 | P04920 | |
| DKRSWFIPPLGSARP | 966 | P48751 | |
| RSRKAPPDGWELIEP | 6 | P41223 | |
| PREFKPTLPGRGWLV | 691 | Q96Q91 | |
| PIDGVRNIPPARWKL | 311 | O95696 | |
| MRPWITEVPRVFAGP | 101 | Q96LX7 | |
| GWPAVLRKLRFTAVP | 331 | P16442 | |
| RVWRSPALIVKGEPP | 76 | Q96LS8 | |
| VSSESIRKGPPVRPW | 571 | Q6ZUJ8 | |
| PLVSPFVSRIWPKKA | 26 | Q8TCD1 | |
| PTPFVSWVRQDGKPI | 271 | Q8TDY8 | |
| TKKGAQPSPFVPVRW | 891 | Q68CQ1 | |
| QPSPFVPVRWVVKVV | 896 | Q68CQ1 | |
| PPVSRDRVIASFPKW | 76 | O95755 | |
| WRNKAVVPPRRSGEP | 901 | Q9H0B3 | |
| RKASRVRVPFPWVGT | 196 | Q9NRN5 | |
| DPPTTKPLTARKFIW | 96 | Q9UI09 | |
| RTTIEKPVWLGFLGP | 81 | P00450 | |
| SEKATLGPAVRPLPW | 121 | P00746 | |
| ASAVWRFKGQLLPPP | 571 | Q8NFP4 | |
| SGPSAPPEEIWVLRK | 366 | Q8WXD9 | |
| PPEEIWVLRKPFAGG | 371 | Q8WXD9 | |
| REGKPRAVIVSWQPP | 956 | P43146 | |
| GLPEPVTLRWKPASQ | 286 | P13747 | |
| PKPEVAWFLEGTPVR | 441 | Q15746 | |
| EPRKGVVPSWPDRSP | 221 | Q9H6Y5 | |
| ALPPWSPPSRTVFAK | 631 | Q49MG5 | |
| PPRITWFKGDRPLSL | 721 | Q96JA1 | |
| PIVFPLWLTVPDVRR | 916 | O60721 | |
| IFIPKFWKLGAPPRE | 626 | Q6PRD1 | |
| TWRRLSEPPTRAVKP | 871 | Q9UKN7 | |
| PQPKLTWFKDGRPLA | 2481 | Q8NDA2 | |
| GVPAPLVSWRKDRVP | 3711 | Q8NDA2 | |
| PRGIQFKRPHTVAPW | 46 | O43561 | |
| VVSAPLVLPWNPGRK | 681 | O75325 | |
| PPGPGRRTLKEWTLQ | 56 | Q8N0U4 | |
| KVDFWRGPARPSLPV | 66 | Q8WXQ8 | |
| PPRGLWQAKDISPIV | 196 | P55107 | |
| VDVARPWLTPKGGAP | 21 | P38570 | |
| RSDGTPFPWNKIRLP | 41 | Q9NZ08 | |
| LPVFLVGFPRPIQSW | 596 | Q63HM2 | |
| GTAIRPLKILPWSPE | 36 | P54315 | |
| PKPLIPTEASIRVWS | 151 | Q9BUK6 | |
| IRGLEILGPKPTFWP | 961 | Q14999 | |
| ILGPKPTFWPVFREQ | 966 | Q14999 | |
| RVPTGYPSDLKPVTW | 351 | Q8WU58 | |
| PTFWPTPKERKNLGL | 281 | Q9H295 | |
| PKPRLTAPNEWRASV | 11 | Q6ZNL6 | |
| SEAPREPVGWPARKR | 31 | A2RU54 | |
| LVVEWAPGVTPKPDR | 446 | Q8TDF6 | |
| SIINFISWAPGKPRP | 906 | Q9UBG0 | |
| AEGFPTPTIKWLRPS | 266 | P32004 | |
| GTPAPRKDPPWITLV | 361 | Q8N3F8 | |
| WVALAARKIPAPFRP | 306 | O75676 | |
| QVKIWRRSYDVPPPP | 111 | Q8N0Y7 | |
| PLQESPRPTGVWKSR | 66 | P16860 | |
| WQKPAGTPVPRIRRL | 111 | Q86UU5 | |
| QPKEITWSPSRVFPP | 1936 | Q9Y4D8 | |
| PAKPQRVVSEGWRRP | 86 | Q8N7R1 | |
| YEWGVRSTRKSEPPP | 31 | Q9BZE1 | |
| PGLRPLVWRGLPFVT | 276 | Q9Y5Y4 | |
| PPKSPLGETRQKLWR | 191 | Q96JZ2 | |
| PVRVPLWVRPGSLAF | 431 | Q9UHB4 | |
| PVTPTFWRVVRFLSP | 386 | Q9BQG0 | |
| ETSIPSVRPPKWLLG | 2401 | Q5VST9 | |
| SDPPPKKRARVQWFV | 76 | Q13415 | |
| EEWVKLPTSAPRPTR | 216 | Q14008 | |
| NIPRLVPGWTKPITI | 156 | P48735 | |
| LSPGLAVKPSWVPRF | 116 | Q6ZN03 | |
| AVKPSWVPRFPLLAR | 121 | Q6ZN03 | |
| TWTPAPRIGFKLGVR | 1106 | P02751 | |
| RITWDPPSSPVKGYR | 846 | Q05707 | |
| IKAHPWTKVFRPRTP | 296 | P49841 | |
| WTKVFRPRTPPEAIA | 301 | P49841 | |
| RVREKPPWRVLFFGT | 41 | Q96DP5 | |
| WILPNVKPFSPSVGR | 291 | Q5VV63 | |
| FWDTSPLLLGKPPRD | 1196 | Q9NS15 | |
| LRFPWSVKLTSSRPP | 656 | Q96L34 | |
| WVAGPKITENPPSRR | 296 | Q9ULL0 | |
| RGVEVLGPKPTFWPL | 1291 | Q8IWT3 | |
| PLRVPPTKLARWVGR | 541 | Q8NFI3 | |
| EEGRWRPFIIRPTPS | 276 | Q13574 | |
| PWSPARRPEVDGVRK | 91 | O95865 | |
| QVKDRGPVVSLWPAP | 266 | Q6UWR7 | |
| IPFRSPTWFGIPRLE | 616 | P78347 | |
| RPGPGAWLRVVLEKP | 161 | O95479 | |
| RAPRVFPVLWTLVSP | 436 | Q92503 | |
| PQPQVTWFRDGRKIP | 141 | Q58EX2 | |
| PARPVFVEGPFSLWL | 281 | Q9BQ95 | |
| QVKIWRRSYDVPPPP | 111 | P18669 | |
| SPGLRRQKRDWVIPP | 146 | P12830 | |
| RQRRPWEPPLDKGTV | 26 | Q9UNU6 | |
| RLSKPEEPPSIWRLF | 31 | Q96LW4 | |
| VPTKSPSAPINWRRG | 351 | Q99759 | |
| SPVPSLGLWRKSPAF | 296 | Q8N9Y4 | |
| PGRDKPDLPTWKRNF | 66 | Q14653 | |
| RQPAPIRGFWIVPDI | 461 | Q99567 | |
| PGTVPKEVRWLRSPF | 56 | Q96PL5 | |
| EPVTPPSKAGRRSFW | 2431 | Q5T011 | |
| RPRWVVPVLPKGELE | 81 | Q93008 | |
| EIQRPPVRVPSWGLE | 656 | Q86VP1 | |
| RSWVPKRQFGSAPPV | 396 | Q8N2I9 | |
| FTKRESPPGKLPFWT | 541 | P52630 | |
| TGWGAIIRKESLPPP | 196 | A6NIE9 | |
| PLSAERVAFPKGLPW | 406 | Q9ULQ0 | |
| FPLWITLPDVRKPSS | 481 | Q9UI40 | |
| LEFPWGPKPFREVIA | 161 | Q6DKJ4 | |
| RGKVKTWPRDDPSQP | 26 | Q92901 | |
| QVKIWRRSFDIPPPP | 111 | P15259 | |
| IRKSWENPPPERSPA | 221 | Q5VWT5 | |
| VIIPPFEDGTPRRGW | 1036 | O60292 | |
| TTGAVRPSDPPKWER | 1206 | Q5T5P2 | |
| VRRKFPLPRTIWDGE | 111 | Q15475 | |
| PGRVPFAVPDKVLWP | 491 | P51692 | |
| SKIPRSRTPGPWLQA | 446 | A6NGB9 | |
| KLALQTGREPPPIWR | 1591 | Q9ULL5 | |
| TGREPPPIWRVQKAL | 1596 | Q9ULL5 | |
| EGPPLRLWRSVIEVP | 1361 | Q96QB1 | |
| PGSVADKRKNPPWIR | 26 | Q96A35 | |
| RDPWPVTQGKRPLRS | 251 | Q15437 | |
| PPLPASRILKEGWER | 501 | Q8IY92 | |
| PGRVPFAVPDKVLWP | 491 | P42229 | |
| VVKPEGSRSPLPWPV | 371 | Q9BWW9 | |
| AGAWSEPRKRSVLPP | 61 | Q8N6S5 | |
| PATTWPVRRGKFNFP | 181 | Q9P291 | |
| GIPSRRHWPVPYKRF | 46 | O75503 | |
| GPWVTVREISRIPYP | 111 | Q9P2J8 | |
| PLNLPLRPGVWTVKI | 811 | Q86Y38 | |
| GWRQVRKITPSLPQP | 61 | Q6ZSR3 | |
| TVFVPSWRKEQPRPD | 176 | Q5D1E8 | |
| PDVRPGAPLRWGIFT | 61 | Q8IUR5 | |
| KRGWLSVPTSRGVPP | 116 | Q6ZSN1 | |
| IPPLRILTPWLFKAT | 1121 | Q6GYQ0 | |
| GDPFPVITWRKVGKP | 446 | Q9UPX0 | |
| RIFPPWQKLIIPSGS | 361 | Q14159 | |
| STWTPVPDERVPKPR | 351 | Q9H2E6 | |
| LEVPEGRPIFLSPWV | 266 | Q5TEJ8 | |
| PLRTVWIARNPPGFA | 36 | Q16629 | |
| PLGSKAPIWIPDTRA | 1211 | Q6ZV73 | |
| PRISWTRGDRTPLPV | 371 | Q92626 | |
| DITVIPKFRPGPRWC | 36 | Q6H3X3 | |
| VPSVIKPTRPDRGWF | 806 | Q9BY07 | |
| ETPARPGLAKKFLPW | 171 | Q9UQQ2 | |
| DITVIPKFRPGPRWC | 36 | Q5VY80 | |
| FLVWKPRPASARAQP | 51 | Q9NPB0 | |
| NRPRWVVPVLPKGEL | 81 | O00507 | |
| PPPVVSWTKVGRGLQ | 446 | Q9P2J2 | |
| QESIWPGGVLPKFPR | 881 | Q92543 | |
| PDFPSKRLPNWRTRG | 61 | Q96L94 | |
| VFVPSWRKDPPRADT | 131 | A2A288 | |
| PGKRPIKRPAYWRTE | 811 | Q9UPP1 | |
| LRVLPSVFWSPPSRK | 51 | Q5PR19 | |
| EWFPQGRPPKVPVRE | 276 | Q15906 | |
| DITVIPKFRPGPRWC | 36 | Q9BZM5 | |
| WLRKPRPVSLFSTPV | 2051 | Q12789 | |
| WPRGLSKLQVPVPTL | 551 | Q9H8Y1 | |
| PPKWIRRPVGASFSF | 386 | O94979 | |
| DNWREFKPGPRIPVI | 111 | Q5VYS8 | |
| RKVPTFATPWPDFVP | 2676 | P01266 | |
| PIKFPHLFTGKRTPW | 146 | Q9UN37 | |
| IPTPRVLWAFPEGVV | 2471 | Q9NR99 | |
| AFSRLKTSLPWVPPD | 126 | O60682 | |
| YVVLSWEPPTPRGKD | 526 | P54296 | |
| VVPFQGKPRPQVVWT | 861 | Q14324 |